The Drug Regulatory Authority of Pakistan (DRAP) has issued an alert warning against the sale and use of a falsified vial version of Hexaxim, a vaccine given to infants and young children to protect them from six serious infectious diseases.
According to the alert, Hoechst Pakistan Limited, Karachi, the local distributor of Sanofi, informed DRAP that batch X3H421VA, which is presented as a Sanofi product in vial form, is not registered or authorised for import into Pakistan. The company said Hexaxim is registered in the country only as a pre-filled syringe.
Health risks linked to the falsified vials
Hexaxim is a ready-to-use, liquid combination vaccine that guards against diphtheria, tetanus, whooping cough, hepatitis B, polio and infections caused by Haemophilus influenzae type b. DRAP warned that the falsified vial could lead to therapeutic failure and adverse effects.
The regulator said its Regulatory Field Force and provincial drug control departments had been instructed to monitor the supply chain and seize the falsified product.
Advice for consumers on vaccines and medicines
DRAP has advised consumers not to buy or use the identified vaccine. Anyone who has used it and experienced a health problem should contact a physician or healthcare provider immediately and report the incident to DRAP or the National Pharmacovigilance Centre.
The authority also urged people to buy medicines and vaccines only from licensed pharmacies and authorised retail outlets, and to check their authenticity and condition before use. Consumers with doubts should consult pharmacists or other healthcare professionals.